PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical application of ethanolic leaf extract significantly increased total collagen and hexosamine content, resulting in a higher rate of wound closure and shorter epithelialization period [PMID:31456291]
Meliadubin B from the bark exhibited significant inflammatory inhibition toward superoxide anion generation in human neutrophils [PMID:37841162]
Meliadubins A and B showed dose-dependent inhibition against the rice pathogenic fungus Magnaporthe oryzae [PMID:37841162]
Evidence summary
PubMed sources
- 1.PMID: 38319486 (2024) — Diaporthe phaseolorum causing dieback disease on Melia dubia cav. in Karnataka state (India). · Archives of microbiology
- 2.PMID: 35002445 (2022) — Seed and seedling diversity delimitation and differentiation of Indian populations of Melia dubia cav. · Saudi journal of biological sciences
- 3.PMID: 37934367 (2023) — Differential gene expression analysis reveals the fast-growth mechanisms in Melia dubia at different stand ages. · Molecular biology reports
- 4.PMID: 31456291 (2019) — Effect of ethanolic extract of Melia dubia leaves on full-thickness cutaneous wounds in Wistar rats. · Dermatologic therapy
- 5.PMID: 36597460 (2023) — Chloroplast genome skimming of a potential agroforestry species Melia dubia. Cav and its comparative phylogenetic analysis with major Meliaceae members.